Westlake Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies (NCT05707325) | Westlake Therapeutics | 2023-01-16 |
Track Westlake Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.